Hypertrophic obstructive cardiomyopathy (HOCM) is the most common genetic heart disease, affecting about 1 in every 500 people, according to the American Heart Association (AHA). In people with HOCM, ...

Treating patients with HCM is guided by how severe symptoms are, whether a patient has any risk factors for sudden cardiac death, and whether a patient has cardiac arrhythmias and other associated ...

The Hypertrophic Cardiomyopathy (HCM) Program at University of Utah Health is one of the nation’s few programs for comprehensive HCM evaluation and management. Our multidisciplinary team works ...

Hypertrophic cardiomyopathy (HCM) is the most common hereditary heart disease. It causes the left ventricle to thicken, the heart muscle to contract too strongly and work too hard. This additional ...

Mavacamten (Camzyos) is the first ever drug to be approved for HOCM found to improve symptoms and may reduce the need for surgery for some people. On April 28, the U.S. Food and Drug Administration ...

The woman, a field geologist, was healthy and active, yet she would pass out at inopportune moments. By Lisa Sanders, M.D. The day was sweltering. The 61-year-old woman urged her donkey into a trot.

Please provide your email address to receive an email when new articles are posted on . Hypertrophic cardiomyopathy is the most common genetic heart disease, with prevalence estimates from one in 200 ...

Despite extraordinary advances in understanding hypertrophic obstructive cardiomyopathy (HOCM) at the molecular and genetic level, the overall clinical management of patients with HOCM remains ...

Despite extraordinary advances in understanding hypertrophic obstructive cardiomyopathy (HOCM) at the molecular and genetic level, the overall clinical management of patients with HOCM remains ...

Dynamic auscultation refers to using maneuvers to alter hemodynamic parameters during cardiac auscultation in order to diagnose the etiology of a heart sound or murmur. The Valsalva maneuver is ...